Plain-English translation of NCT07802847 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
France
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Enrollment target
~794 participants
Started
September 2026
Primary completion
September 2031
Age range
70 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Arnaud BAYLE
Gustave Roussy, Cancer Campus, Grand Paris
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.